Sonoma Pharmaceuticals Inc. (Nasdaq: SNOA) posted its first pre-tax net income in the third quarter of 2026.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.